Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?

QR Code

Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?

Bibliographic Details
Main Author:	Chan, Arlene
Format:	Journal Article
Published:	2017
Online Access:	http://hdl.handle.net/20.500.11937/58267

Similar Items

Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Factors affecting utilisation of biosimilar medicines in England
by: Alnahar, Saja
Published: (2018)

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study
by: Au, H., et al.
Published: (2013)

Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2013)

Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah … [et al.]
by: Hasbullah, Harissa H, et al.
Published: (2018)

Biosimilar uptake by British local formularies: a cross sectional study
by: Alnahar, Saja, et al.
Published: (2017)

AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer
by: Gianni, L., et al.
Published: (2013)

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
by: Chan, Arlene, et al.
Published: (2016)

Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens
by: Chan, Arlene, et al.
Published: (2018)

Use of non anthracycline regimens in early stage breast cancer within Australia
by: De Boer, R., et al.
Published: (2011)

TILs in metastatic breast cancer—no surprises, but more questions
by: Chan, Arlene
Published: (2017)

Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients
by: Chan, Arlene, et al.
Published: (2014)

Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)

Multifunctional Poly(D,L-Lactide-co-Glycolide)/ Montmorillonite (PLGA/MMT) Nanoparticles Decorated by Trastuzumab for Targeted Chemotherapy of Breast Cancer
by: Ranganathan, Balu, et al.
Published: (2014)

How are the kids? Psychosocial wellbeing and needs of the offspring of breast cancer patients
by: Chih, Hui Jun, et al.
Published: (2019)

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy
by: Chan, Arlene, et al.
Published: (2013)

Neratinib in HER-2-positive breast cancer: Results to date and clinical usefulness
by: Chan, Arlene
Published: (2016)

The role of the breast care nurse during treatment for early breast cancer: the patient's perspective.
by: Halkett, Georgia
Published: (2006)

HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
by: Martin, M., et al.
Published: (2017)

Reliable early breast cancer detection using artificial neural network for small data set
by: Vijayasarveswari, V., et al.
Published: (2021)

Breast conserving therapy versus mastectomy in young breast cancer patients in asian settings / Siamala Sinnadurai
by: Siamala, Sinnadurai
Published: (2018)

Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer
by: Alfarsi, Lutfi, et al.
Published: (2018)

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2010)

UWB-based early breast cancer existence prediction using artificial intelligence for large data set
by: Ahmad Ashraf, Abdul Halim, et al.
Published: (2023)

Transcriptomic profiling and validation of early onset estrogen receptor-positive breast cancer patients
by: Siddig, Alaa Abdelaziz Mahmoud
Published: (2023)

Breast cancer bone metastases: pathogenesis and therapeutic targets
by: Brook, Naomi, et al.
Published: (2018)

Breast cancer etiologies among young Malay breast cancer patients
by: Sulaiman, Szariannie, et al.
Published: (2020)

Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol
by: Goyal, Amit, et al.
Published: (2013)

Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease
by: Inns, Joseph, et al.
Published: (2015)

IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
by: Ahmad, Narmeen, et al.
Published: (2018)

Knowledge, perception and practice of breast self examination among daughter of breast cancer patient and daughter of non breast cancer patient, 1999
by: Khalijah Mohd Yusof,, et al.
Published: (2006)

A UWB imaging system to detect early breast cancer in heterogeneous breast phantom
by: Saleh, Alshehri, et al.
Published: (2011)

A UWB imaging system to detect early breast cancer in heterogeneous breast phantom
by: Alshehri, Saleh Ali, et al.
Published: (2011)

Controversial issues in the management of older adults with early breast cancer
by: Mislang, Anna Rachelle, et al.
Published: (2017)

The phenomenon of making decisions during the experience of early breast cancer
by: Halkett, Georgia, et al.
Published: (2007)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)

Investigating depression among breast cancer patients
by: Nur Aziera, binti Wahid
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_thtb6s0hasl3doj7402jcf33un